| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0B | $1.8B | $1.6B | $1.4B | $1.3B | $1.1B | $0.3B | $0.3B |
| Cost of Revenue | — | — | — | — | — | — | $1.0B | $0.9B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B | $0.0B | $0.1B | $0.0B |
| Net Income | $-0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $-0.0B | $0.0B | $0.0B |
| EPS (Basic) | $-0.25 | $0.04 | $0.05 | $0.19 | $0.47 | $-0.29 | $0.21 | $0.60 |
| EPS (Diluted) | $-0.25 | $0.04 | $0.05 | $0.17 | $0.46 | $-0.29 | $0.21 | $0.59 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.8B | $3.3B | $2.7B | $2.4B | $2.1B | $1.8B | $1.6B | $1.1B |
| Current Assets | $1.0B | $1.0B | $0.6B | $0.4B | $0.3B | $0.3B | $0.2B | $0.2B |
| Cash & Equivalents | $0.8B | $0.7B | $0.3B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B |
| Total Liabilities | $2.4B | $2.2B | $1.9B | $1.9B | $1.7B | $1.5B | $1.4B | $0.9B |
| Current Liabilities | $0.6B | $0.5B | $0.4B | $0.5B | $0.4B | $0.4B | $0.3B | $0.2B |
| Stockholders' Equity | $1.1B | $0.9B | $0.6B | $0.3B | $0.2B | $0.2B | $0.2B | $0.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.3B | $-0.2B | $-0.2B | $-0.2B | $-0.2B | $-0.1B | $-0.1B | $-0.1B |
| Capital Expenditures | — | — | — | — | — | — | $0.1B | $0.1B |
| Financing Cash Flow | $0.1B | $0.4B | $0.2B | $0.1B | $0.1B | $-0.0B | $0.0B | $-0.0B |